German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced the distribution of Histasolv®, a leading product targeting histamine food intolerance, under its new partnership with STADA ...

He added that the new site enhances Stada’s capacity "to deliver quality healthcare products throughout Europe." Part of the ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved or endorsed by any other entities, such as banks, credit card issuers or ...

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

Stada, which sells generic drugs and consumer health products, is preparing for an IPO in Frankfurt that would be among the largest in European pharma in recent years. According to a person ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...